Between these, MAGE-C1/CT7 (from now on CT7) and MAGE-C2/CT10 (from now on CT10) are highly expressed in cutaneous melanoma (CM), represent strong prognostic markers [5], and spontaneously induce a specific cellular immune response in melanoma patients [6, 7]. Here, MAGEC1 is linked to cutaneous melanoma.